Serum Immunoglobulins, Complement Levels and Lymphocyte Subpopulations in Phenytoin-Treated Epileptic Patients
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Immunopharmacology and Immunotoxicology
- Vol. 11 (2-3) , 335-346
- https://doi.org/10.3109/08923978909005374
Abstract
The peripheral blood lymphocytes, serum immunoglobulins, C3 and C4 complement protein concentrations of 20 patients with idiopathic epilepsy who were receiving phenytoin were examined and compared with 30 healthy controls in order to obtain a detailed profile of the effects of the drug on the humoral and cellular immune systems. The T-lymphocyte subsets were identified using monoclonal antibodies. A significant decrease in suppressor T-cells (p < 0.05) and an increase in the ratio of T-helper to T-suppressor lymphocytes (p < 0.01) have been found. Furthermore, an increase in B-lymphocytes (p < 0.01) and a significant rise in serum IgM concentrations (p < 0.05) have been observed. No significant changes in serum concentrations of IgG, IgA and complement proteins were detected.This publication has 29 references indexed in Scilit:
- Mortality in Patients with EpilepsyEpilepsia, 1980
- ANTICONVULSANT DRUGS AND CANCER A Cohort Study in Patients with Severe EpilepsyThe Lancet, 1979
- Malignant lymphoma after diphenylhydantoin (dilantin) therapyCancer, 1975
- Effect of Antiepileptic Drugs on Serum and Salivary IgAScandinavian Journal of Immunology, 1975
- Serum immunoglobulins in epilepsyJournal of the Neurological Sciences, 1974
- ARE ANTICONVULSANTS ONCOGENIC?The Lancet, 1974
- Immunological Abnormalities and HydantoinsBMJ, 1972
- Diphenylhydantoin Effects on Human Lymphocytes in Vitro and in VivoArchives of internal medicine (1960), 1972
- DEPRESSION OF IMMUNOLOGICAL FUNCTION IN PATIENTS TREATED WITH PHENYTOIN SODIUM (SODIUM DIPHENYLHYDANTOIN)The Lancet, 1971
- Malignant Lymphoma Associated With Hydantoin DrugsArchives of Neurology, 1970